NCT04067336
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04067336
Title First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Kura Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
UCLA Ronald Reagan Medical Center Los Angeles California 90095 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611 United States Details
University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Michigan Hospitals Ann Arbor Michigan 48109 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Hackensack University Medical Center - John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 United States Details
Weill Cornell Medical College - NY Presbyterian Hospital New York New York 10021 United States Details
The Mount Sinai Hospital New York New York 10029 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Oklahoma University Health - Stephenson Cancer Center Oklahoma City Oklahoma 73117 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Harold C. Simmons Comprehensive Cancer Center - UT Southwestern Medical Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
AZ Delta - Campus Rumbeke Roeselare 8800 Belgium Details
Queen Elizabeth II Health Sciences Centre Halifax Nova Scotia B3H 1V7 Canada Details
Hopital Maisonneuve-Rosemont Montreal Quebec H1T 2M4 Canada Details
Hopital de l'Enfant-Jesus - Centre Integre en Cancerologie du CHU de Quebec - Universite Laval Québec Quebec G1J 1Z4 Canada Details
Centre Hospitalier Universitaire de Lille Lille 59037 France Details
Centre Hospitalier Universitaire de Nantes Nantes 44093 France Details
Hopital Saint Louis Paris 75475 France Details
Magendie Hopital Haut-Leveque Pessac 33600 France Details
Centre Hospitalier Lyon Sud Pierre-Bénite 69310 France Details
Institut Gustave Roussy Villejuif 94800 France Details
University Medicine Greifswald Greifswald 17475 Germany Details
Medizinische Hochsschule Hannover Hanover 30625 Germany Details
Institute of Hematology and Medical Oncology "L. and A. Seragnoli" Bologna 40138 Italy Details
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" Meldola 47014 Italy Details
UO Ematologia Ospedale di Ravenna Ravenna 48121 Italy Details
Institution Fondazione Policlinico Tor Vergata Roma Italy Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Universitat de Barcelona Barcelona 08035 Spain Details
MD Anderson Cancer Center Madrid 28033 Spain Details
Hospital Universitario HM Sanchinarro Madrid 28050 Spain Details
Hospital Universitario Central de Asturias Oviedo 33011 Spain Details
Hospital Universitario Virgen del Rocio Seville 41013 Spain Details
Hospital Universitari i Politecnic La Fe Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field